• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • Masitinib
      • NurOwn
      • CNM-Au8
      • ILB
      • AstroRx
      • Neuronata-R / Lenzumestrocel
      • PrimeC
      • NP001
      • Pridopidine
      • SOD1 Therapies and Trials
      • C9orf72 Therapies and Trials
      • SPG302
      • Regulatory T Cell Enhancing Therapies
      • Ulefnersen
    • Approved Drugs
      • Nuedexta
      • Radicava / Edaravone
      • Riluzole / Tiglutik
      • Rozebalamin / Methylcobalamin
      • Tofersen / Qalsody
    • Drugs No Longer in Development
      • AMX0035
      • Reldesemtiv
      • Arimoclomol
      • TUDCA
      • CuATSM
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Forbes Norris Award

The Forbes Norris Award was established in 1994 to honour the legacy of Dr. Forbes “Ted” Norris (1928–1993), a neurologist who dedicated his life to supporting people living with ALS/MND. This prestigious award recognizes individuals whose work advances clinical care, research, and understanding of ALS/MND for the benefit of those living with the disease.

To be considered for the Forbes Norris Award, candidates must:

  • Play a major role in delivering outstanding ALS/MND patient care
  • Contribute significantly to medical literature in clinical management or basic science related to ALS/MND
  • Be part of a team engaged in ongoing research into ALS/MND care, management, or basic science

The award is presented annually during the opening ceremony of the MND Association’s International Symposium on ALS/MND. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15.

Forbes Norris Award Nomination Form

  • (No self-nominations please)
  • Accepted file types: doc, docx, pdf, Max. file size: 128 MB.
    Please use .doc, .docx, or .pdf
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Jan Zuring, Netherlands

    Jan Zuring, Netherlands

  • Alfredo Santos, Colombia

    Alfredo Santos, Colombia

  • Maria Santos Garcia Tellez, Mexico

    Maria Santos Garcia Tellez, Mexico

  • Olga, Argentina

    Olga, Argentina

  • Bob Spurrier, USA

    Bob Spurrier, USA

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Alberto Baez Murillo, Colombia

    Alberto Baez Murillo, Colombia

  • Elkin Gaviria, Colombia

    Elkin Gaviria, Colombia

  • Ailsa Malcolm-Hutton, UK

    Ailsa Malcolm-Hutton, UK

  • Sanjay Kumar Srivastava, India

    Sanjay Kumar Srivastava, India

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Mauril Belanger, Canada

    Mauril Belanger, Canada

  • Jorge Melo, Brazil

    Jorge Melo, Brazil

  • Susan Anderson, USA

    Susan Anderson, USA

  • Bruno Leanza Mantegna, Italy

    Bruno Leanza Mantegna, Italy

  • Claudette Sturk, Canada

    Claudette Sturk, Canada
    Picture2

  • Orlando Ruiz, Colombia

    Orlando Ruiz, Colombia

  • Shera Mukherjee, India

    Shera Mukherjee, India

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Roy Taylor, Ireland

    Roy Taylor, Ireland
    roy

  • Jean Waters, UK

    Jean Waters, UK

  • Rosie Riley, USA

    Rosie Riley, USA

  • Ismail Gokcek, Turkey

    Ismail Gokcek, Turkey
    ismail_gokcek_alsmnd_tr

  • Soledad Rodriguez, Spain

    Soledad Rodriguez, Spain

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Mike Cels, Canada

    Mike Cels, Canada

  • John Dinon, Australia

    John Dinon, Australia

  • Lineke Veenstra, Netherlands

    Lineke Veenstra, Netherlands

  • Juvenal Bayona Romero, Colombia

    Juvenal Bayona Romero, Colombia

  • Claudia Cominetti, Italy

    Claudia Cominetti, Italy

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Paul Launer, USA

    Paul Launer, USA

  • Carlos Gomez Matallanas, Spain

    Carlos Gomez Matallanas, Spain

  • Tso-Ta Huang, Taiwan

    Tso-Ta Huang, Taiwan

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Oliver Juenke, Germany

    Oliver Juenke, Germany

  • Mary Thomas, Australia

    Mary Thomas, Australia

  • Zelina Brito, Brazil

    Zelina Brito, Brazil

  • Manuel Arn, Switzerland

    Manuel Arn, Switzerland

  • David Bishop, UK

    David Bishop, UK

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Teddy Hanono Annie, Mexico

    Teddy Hanono Annie, Mexico

  • Ian Gale, Australia

    Ian Gale, Australia

  • Colm Francis Davis, Ireland

    Colm Francis Davis, Ireland

  • Angela Jansen, Germany

    Angela Jansen, Germany

  • Ali Var, Turkey

    Ali Var, Turkey

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login